and numerous genetic loci for obesity susceptibility were identified (Heard-Costa et al., 2009; Lindgren et al., 2009; Speliotes et al., 2010; Thorleifsson et al., 2009; Willer et al., 2009) . These loci are functionally linked to hypothalamic regulators of appetite or energy balance, glucose and energy metabolism, platelet-derived growth factor signaling, hormone or nuclear hormone binding, translation elongation and immune processes. In addition to the genetic factors, epigenetic factors play critical roles in obesity and metabolic regulation (Dabelea et al., 2008; Stein, Zybert, van de Bor, & Lumey, 2004; Tobi et al., 2014; Waterland & Jirtle, 2004) , although both factors are intimately intertwined.
Distinct posttranslational modifications of the histone tail can provide platforms that facilitate synergistic and antagonistic interactions of chromatin-associated proteins, resulting in positive and negative regulation of transcription (Jenuwein & Allis, 2001 ). KDM4B (also called JMJD2B) belongs to a subfamily of histone demethylases that catalyze the removal of methyl moieties from H3K9me2/3 and H3K36me2/me3. Three members of the subfamily, KDM4A, KDM4B and KDM4C, share conserved catalytic domain structure and substrate specificity. Recent accumulating evidence suggests that KDM4B is implicated in multiple human diseases (Fujiwara et al., 2016; Pedersen & Helin, 2010) . The oncogenic activities of KDM4B have been extensively investigated in multiple cancers, including medulloblastoma (Northcott et al., 2009; Yang et al., 2015) and breast cancer (Kawazu et al., 2011; Yang et al., 2010) . Our in vivo studies using mammary gland-specific knockout mice identified that KDM4B regulates the estrogen receptor signaling and is required for mammary gland development (Kawazu et al., 2011) . In terms of metabolism, Kdm4b depletion inhibited adipocyte differentiation of 3T3-L1 preadipocytes in vitro (Guo et al., 2012; Jang, Kim, & Jung, 2017 ). Yet, Kdm4b's roles in energy balance, metabolism and obesity are unclear, especially in vivo.
In this study, we describe a novel role for Kdm4b in controlling energy expenditure. Inactivation of Kdm4b in adipose tissues accelerated high fat diet (HFD)-induced obesity and metabolic disorders due to energy imbalance caused by mitochondrial dysfunction.
| RESULTS

| Kdm4b/Jmjd2b deletion in adipose tissues induced obesity
We first examined Kdm4b expression in multiple organs involved in metabolic regulation in both mice and humans. Kdm4b is expressed in white adipose tissue (WAT), brown adipose tissue (BAT), skeletal muscle and the liver with relatively higher levels in BAT and skeletal muscle (Figure 1a) . The expression levels in each organ were comparable between males and females. To better understand the role of Kdm4b in adipose tissues, we generated adipocyte-specific Kdm4b knockout mice by breeding our mice carrying a floxed Kdm4b allele (Kawazu et al., 2011) with mice carrying the aP2 promoter-Cre transgene (He et al., 2003 ; aP2-Cre (K4bKO) mice were viable and born at a normal Mendelian ratio (data not shown).
We monitored the body weights of HFD (11% fat content)-fed Con, K4bKO f/+ and K4bKO mice for 16 weeks from birth.
Although the three genotypes showed similar weights when weaned from their mother at 4 weeks old, the weight gain of the K4bKO mice increased by 8 weeks. By 12-16 weeks, K4bKO females gained an average of 10 g more weight than the Con group and K4bKO males gained 6 g more than Con mice ( Figure 1b) . The K4bKO f/+ mice showed a trend toward gaining more weight than the Con mice, but the difference was not significant under these experimental conditions. As the weight gain phenotype was observed at an earlier time point in females, we mainly used females for the subsequent analyses. The body size of K4bKO mice was much larger with increased sizes of inguinal and visceral WAT, BAT and the mammary fat pad (Figure 1c and data not shown). To monitor the weight gain phenotype over time, Con and K4bKO mice were fed either normal chow diet (NCD) or a HFD and monitored for 30 weeks. The weight gain of K4bKO mice was accelerated by a HFD without any changes in food intake ( Figure 1d ). These data indicate that Kdm4b functions to inhibit fat accumulation in adipose tissues.
F I G U R E 1
The adipocyte-specific Kdm4b deletion induced obesity in mice. (a) Kdm4b mRNA expression levels in mice and human tissues involved in metabolism. Kdm4b mRNA levels were evaluated by qRT-PCR in wild-type C57BL/6J mice. The results represent mRNA levels normalized to the level of Actb mRNA (n = 3) (left). The Genotype-tissue expression (GTEx) KDM4B RNA sequence data were analyzed, and the distributions of KDM4B in the indicated male (M) and female (F) 
| Kdm4b deficiency in adipocytes induced fat accumulation in adipose tissues and the liver
To gain further insights into the weight gain phenotype, we carried out histological and gene expression analyses in inguinal WAT and the liver. The cell diameters of K4bKO adipocytes were increased twofold to threefold with increased fat content in the cytosol, reflecting an eightfold to 27-fold increase in volume ( Figure 2a ). Consistent with fat accumulation and the enlargement of adipocytes, the expression levels of adipose differentiation markers, such as PPARγ and aP2, were upregulated in K4bKO adipocytes ( Figure 2b ). Adipokine, including leptin and resistin, expression levels were also increased in K4bKO adipocytes. On the contrary, the expression level of PGC-1α, a critical regulator of energy expenditure, was down-regulated in K4bKO adipocytes ( Figure 2b ). Hematoxylin and eosin (H&E) staining of the liver sections exhibited gross lipid accumulation in hepatocytes ( Figure 2c ), indicating profound hepatic steatosis. The size and the weight of the liver in HFD-fed K4bKO mice were increased ( Figure 2d ). The expression levels of the genes involved in triacyl glycerol synthesis, adipose differentiation and lipid metabolism were slightly upregulated in HFD-fed mice by 4 months. The upregulation of these genes became more prominent in HFD-fed mice by 10 months, suggesting there was progressive steatosis in the liver of K4bKO mice ( Figure 2e ). These data indicate that Kdm4b deficiency in adipocytes enhanced fat accumulation in adipose tissues, which in turn resulted in systemic metabolic disorders. Thus, these findings contribute to a better understanding of the pathogenesis of obesity-induced complications in humans.
| Kdm4b deficiency in the glucose and lipid metabolism of adipocytes
Because of the progressive fat accumulation in adipose tissues and liver, which are indicative of systemic metabolic dysfunction, several metabolic parameters were measured. At 6 months of age, HFD-fed K4bKO mice exhibited higher fasted glucose levels ( Figure 3a) . A glucose tolerance test showed that K4bKO mice suffered glucose intolerance ( Figure 3b ). When evaluating lipid metabolism, K4bKO mice exhibited higher triacylglycerol and cholesterol levels than Con mice ( Figure 3c ). In addition, alanine transaminase (ALT) levels were significantly increased in K4bKO mice (Figure 3d ), which is consistent with the profound hepatic steatosis observed in these mice. The hepatic enzymes, ALT and aspartate transaminase (AST), are increased in nonalcoholic steatotic hepatitis and ALT is a clinically relevant predictor of hepatic steatosis in humans (Marchesini, Moscatiello, Di Domizio, & Forlani, 2008) .
| Decreased energy expenditure in
Kdm4b-deficient cells
The progressive fat accumulation in multiple organs in K4bKO mice led us to speculate that Kdm4b deficiency influences energy consumption in adipocytes. To test this, we prepared stromal vascular fractions (SVFs), which included adipose-derived stem cells (ADSCs) (Bunnell, Flaat, Gagliardi, Patel, & Ripoll, 2008) , from the inguinal adipose tissue of Con and K4bKO female mice, and measured the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR). The OCR and ECAR were both decreased in the cells from K4bKO mice compared with those from Con mice (Figure 4a ). In addition, the expression levels of some mitochondrial genes were decreased (Figure 4b ). These data strongly suggest that Kdm4b deficiency decreases energy expenditure by suppressing mitochondrial functions.
| DISCUSSION
Obesity is currently a serious global health issue. Metabolic dysfunction disorders, such as diabetes, hyperlipidemia and atherosclerosis, occur as a consequence of obesity, supporting that adipose tissue is a critical coordinator of systemic metabolism. We showed that the inactivation of Kdm4b in adipocytes induced obesity in mice. Although the obesity phenotype was observed in both males and females, the onset of weight gain appeared to be earlier and progress faster in females. The K4bKO mice exhibited increased WAT and higher expression levels of adipogenesis-related and adipokine genes. In addition, there was concomitant progression of glucose intolerance, hyperglycemia and hepatic steatosis with increased ALT levels observed in the K4bKO mice, similar to the observations in human patients with pathological obesity. Furthermore, the genes critical for energy expenditure were down-regulated and mitochondrial functions were impaired in the SVF of K4bKO mice. Thus, these data indicate that Kdm4b is a critical regulator of systemic metabolism via enhancing energy expenditure in adipocytes.
In cases of overnutrition and/or low energy expenditure, adipocytes become hypertrophic and adipose depots expand to store excess energy. Once a critical threshold is reached, preadipocytes proliferate and differentiate (Krotkiewski, Bjorntorp, Sjostrom, & Smith, 1983 ). In our model, although Kdm4b depletion reduced adipogenesis in vitro (Guo et al., 2012; Jang et al., 2017) (Figure S1 ), Kdm4b inactivation in adipocytes induced a progressive increase in the total adipose mass in vivo. This was a result of decreased energy expenditure due to mitochondrial dysfunction, although the detailed molecular mechanisms of how Kdm4b deficiency reduces energy expenditure and mitochondrial functions remain unclear. Nonetheless, these findings suggest that energy balance is predominant in regulating the total adipose mass and adipocyte differentiation. Supporting this notion, total body fat usually recovers even when fat pads are surgically removed (Mauer, Harris, & Bartness, 2001 ). However, these findings with humans and our mouse models do not necessarily exclude that deregulated adipocyte differentiation does not cause obesity or that adipocytes have any role in the regulation of energy balance. As a matter of fact, obesity can be subdivided into two groups: hypertrophic obesity caused by enlarged fat cells and hyperplastic obesity caused by an increased number of fat cells (Hirsch & Knittle, 1970) . The hypertrophic subgroup is more closely associated with metabolic complications (Bjorntorp, Gustafson, & Persson, 1971 ). H3K9 methylation plays critical roles in fat metabolism. The histone H3K9 methyltransferases, SETDB1 and G9a, inhibit adipogenesis by suppressing the expression of adipogenic genes, including PPARγ and C/EBPβ (Musri et al., 2010; Wang et al., 2013) , whereas SETDB1 and G9a deletions promote adipogenesis. However, the H3K9 demethylase, Kdm3a, helps prevent obesity by regulating metabolic genes including Ucp1 (Inagaki et al., 2009; Tateishi, Okada, Kallin, & Zhang, 2009) . Taken together, the H3K9 methylation status of adipogenic genes is crucial for proper regulation of fat metabolism and energy balance.
F I G U R E 3
Although we were preparing this manuscript, Cheng et al. (2018) reported that Kdm4b −/− mice became obese. In addition to the obesity phenotype in the conventional Kdm4b knockout mice, they showed that adipocyte-specific deletion of Kdm4b ( ; aP2-Cre) induced obesity. They identified that the genes critical for energy expenditure, oxidation and lipolysis, including Ppar, Ppargc1a, Acox1 and Atgl, were Kdm4b targets. Interestingly, they found that the Ucp-1 expression levels were unchanged. This is a great contrast to the pathogenesis of Kdm3a deficiency-induced obesity, in which Ucp-1 downregulation was critical (Tateishi et al., 2009) , although there was some controversy with this finding (Inagaki et al., 2009) . We observed that Ucp-1 expression levels were comparable between Con and K4bKO mice, although slightly increased in some K4bKO mice (data not shown), which may reflect a feedback response to the decreased energy expenditure in Kdm4b KO mice. We used aP2-Cre to inactivate Kdm4b in adipocytes and the overall obesity phenotype was similar to that found in the Cheng et al. study, with some differences. Most of our Kdm4b −/− mice exhibited embryonic lethality with the C57BL/6 background (Kawazu et al., 2011 ) (data not shown). Although only limited numbers of Kdm4b knockout mice were available to analyze, we found severe fat accumulation in the skeletal muscle of 7-month-old Kdm4b −/− mice ( Figure S2 ), but not in those of wild-type and K4bKO mice. These observations suggest that Kdm4b functions in multiple tissues to balance energy metabolism. Supporting this idea, Kdm4b was reported to regulate myogenic differentiation in C2C12 myoblast cells in vitro (Choi, Song, & Lee, 2015) . Cheng et al. showed that Kdm4b did not influence adipogenesis in vitro; however, Kdm4b depletion suppressed adipogenesis in 3T3-L1 cells (Guo et al., 2012; Jang et al., 2017) ( Figure S1 ). In any case, further lineage tracing experiments in vivo will clarify this discrepancy. Kdm4b is involved in estrogen signaling (Gaughan et al., 2013; Kawazu et al., 2011; Yang et al., 2010) . Thus, our findings in Kdm4b-deficient female mice may mimic the adiposity observed postmenopause when energy expenditure is decreased (Mauvais-Jarvis, 2011). Obesity is often associated with insulin resistance. Proinflammatory cytokines, adipokines and fatty acids secreted from adipose tissues contribute to the establishment of insulin resistance (Kahn, Hull, & Utzschneider, 2006) . Dysfunctional pancreatic islet beta cells are often observed. Thus, abnormalities in beta-cell function are critical in defining the risk and development of obesity-associated insulin resistance. Although the dynamics of beta-cell mass is influenced by several factors including age and underlying condition, the increase in beta-cell mass was observed in the cases with obesity-associated insulin resistance (Kloppel, Lohr, Habich, Oberholzer, & Heitz, 1985; Rahier, Guiot, Goebbels, Sempoux, & Henquin, 2008) . Supporting these reports, Kdm4b-deficient obesity mice showed the increase in beta-cell mass (Cheng et al., 2018) .
Epigenetics involves the altering and reprogramming of gene expression in response to environmental changes. This study and previous studies identified and established that histone methylation is critical for the regulation of energy expenditure, fat metabolism and adipogenesis in vivo. In other words, the epigenetic information regulating the balance between energy balance and metabolism, at least in part, can be stored on chromatin. Thus, it is intriguing to speculate the existence of epigenetic regulators of which deficiency or over-expression reduces body fat when a HFD is consumed. The identification of such epigenetic regulators will uncover the pathways involved in sensing excess food intake and coordinating energy balance in our bodies.
In summary, this study significantly broadens our understanding of the complexity of epigenetics mediating metabolic regulation in vivo. Further investigation of the Kdm4b signaling pathway may lead to novel therapeutic approaches for obesity and metabolic disorders.
| EXPERIMENTAL PROCEDURES
| Animals
Mice were maintained in pathogen-free conditions in accordance with the Institutional Animal Care and Use Committees of the Kindai University Faculty of Medicine and University Health Network. All mice had a C57BL/6J background. The gene targeting strategy of the floxed Kdm4b (Jmjd2b flox/flox ) mice was described previously (Kawazu et al., 2011) . The aP2-Cre transgenic (aP2-Cre) mice (He et al., 2003) were obtained from The Jackson Laboratory (Bar Harbor, ME, USA). All mice were housed in a mouse facility on a 12-hr light/dark cycle in a 22°C temperature-controlled room. Male and female mice were used for experiments and were matched for age and sex.
| Metabolic analysis
Blood samples were obtained from mice who overnight fasted for 16 hr by puncture of the left ventricle after treatment with carbon dioxide. For the glucose tolerance test, after overnight fasting for 16 hr, 2 mg/g glucose was orally administrated. Blood samples were obtained from the tail vein and blood glucose levels were measured with a glucometer according to the company's instructions.
| Histology
Tissue samples were fixed with neutral-buffered 10% formaldehyde. Paraffin-embedded tissues were sectioned with a 5 μm thickness and stained with H&E. For oil red O staining, tissue samples were immersed in 10% sucrose/PBS solution overnight at 4°C and replaced with 20% sucrose, then stained with oil red O (Abcam).
| Cell culture
Cells were isolated from inguinal adipose tissue from C57BL/6J 8-to 10-week-old female mice. Fat pads were excised and digested at 37°C in PBS containing 0.2% BSA and 1 mg/ml collagenase for 30 min. After elimination by filtration, a SVF including ADSCs was obtained by centrifugation (600 g, 10 min). The SVF cells were cultured in DMEM:F12 containing 10% fetal bovine serum (FBS), fibroblast growth factor (10 ng/ml) and penicillin/ streptomycin.
| Quantitative real-time PCR
Total RNA was extracted using the RNeasy plus Mini Kit (Qiagen). First-stranded cDNA was synthesized using the Genes to Cells KANG et Al.
iScript
TM cDNA Synthesis Kit (Bio-Rad), followed by PCR specific for the target genes. The real-time quantitative PCR was carried out using SYBR Green PCR Master Mix (ThermoFisher Scientific), and the data were collected using the PlusOne Fast Real-time PCR system (Applied Biosystems). The sequences of the primers used in this study are in Table S1 .
| RNA interference
The Kdm4b shRNA, the pLKO.1 puro (Addgene plasmid #8453) (Sarbassov, Guertin, Ali, & Sabatini, 2005; Stewart et al., 2003 ) lentiviral vector and control scrambled shRNA (Addgene plasmid #1864) (Sarbassov et al., 2005) were used to deplete Kdm4b in 3T3-L1 cells. The lentivirus was prepared by transfecting 293T cells with the knockdown vectors, pMD2.G (Addgene plasmid #12259) and psPAX2 (Addgene plasmid #12260).
| Gene expression in human tissues
The Genotype-Tissue Expression (GTEx) RNA sequence data for the indicated tissues were obtained from the human protein atlas website (https://www.proteinatlas.org/tissue) and analyzed.
| Measurement of the OCR and ECARs
The XF96 Extracellular Flux analyzer (Agilent, Santa Clara, CA, USA) was used to measure OCR and ECAR in SVF cells prepared from Kdm4b flox/flox and Kdm4b flox/flox ; aP2-Cre mice as previously described (Wu et al., 2007) . Briefly, the cells were seeded at 20,000/well on XF96 plates and incubated in a humidified 37°C incubator with 10% CO 2 for 24 hr followed by the XF assay. The assay was carried out with the XF Assay Medium (Agilent) according to manufacturer's instructions. All assays were carried out in triplicate.
| Culture and differentiation of 3T3-L1 cells to adipocytes
The 3T3-L1 cells were purchased from ATCC (Manassas, VA, USA) and cultured in DMEM supplemented with 10% calf serum (Invitrogen, Burlington, ON, Canada) and penicillin/streptomycin at 37°C with 5% CO 2 . For adipocyte differentiation, confluent 3T3-L1 cells were cultured in DMEM containing 10% FBS (Invitrogen), 1 μg/mL insulin (Sigma-Aldrich, St Louis, MO, USA), 0.5 mM isobutylmethylxanthine (Sigma-Aldrich) and 1 μM dexamethasone (Sigma-Aldrich) for 2 days, followed by an additional 2-day culture in DMEM with 10% FBS and 1 μg/mL insulin. Then, culture medium was switched to DMEM with 10% FBS and changed every other day.
| Statistical analysis
Data are presented as the mean ± SD. Student's t test was used for comparisons. A value of p < 0.05 was considered indicative of significance in all tests. Investigators were not blinded to allocation during the experiments and outcome assessment.
